Pfizer ( Pfizer)

Primary tabs

Pfizer's picture

Management

Charles Pfizer is one of the Founder of the Company. He was born on March 22, 1824 in Germany. Albert Bourla is the CEO of the Company. Ian Read is the Chairman and He was born in Scottland. He received a bachelor's degree in chemical engineering from Imperial College London in 1974.

Contact Address

New York City, United States

About Pfizer

Pfizer Inc. is an American pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. On December 19, 2018, Pfizer announced a joint merger of their consumer healthcare division with UK pharma giant GlaxoSmithKline; the British company will maintain a controlling share (listed at 68%).

Pfizer press release, blog etc

Mon, 08/22/2022 - 14:22 Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (containing benzyl alcohol), Due To The Potential Presence of Visible Particulates
Mon, 04/11/2022 - 07:49 Pfizer Names David M. Denton Chief Financial Officer
Tue, 02/08/2022 - 20:21 Cures found in nature
Fri, 02/04/2022 - 19:15 Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate
Tue, 02/01/2022 - 17:52 Pfizer Announces New Chief Development Officer
Mon, 01/31/2022 - 18:18 Pfizer and Ionis Announce Discontinuation of Vupanorsen Clinical Development Program
Thu, 01/20/2022 - 23:41 Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency
Mon, 01/10/2022 - 04:33 Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases
Sun, 01/09/2022 - 22:51 Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics
Wed, 12/15/2021 - 17:13 Pfizer Invests $68.5 Million in New State-of-the-Art Facility in Durham, North Carolina to Further Advance Gene Therapy Capabilities
Fri, 12/10/2021 - 04:11 Pfizer Declares First-Quarter 2022 Dividend
Wed, 12/01/2021 - 20:49 AWS Helps Pfizer Accelerate Drug Development and Clinical Manufacturing
Wed, 11/24/2021 - 18:54 Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY in Children 5 to under 12 Years of Age in the European Union
Fri, 11/19/2021 - 13:27 Arvinas and Pfizer Announce Updated Phase 1 Dose Escalation Data for ARV-471 to be Presented in Spotlight Poster Session at 2021 San Antonio Breast Cancer Symposium
Wed, 11/17/2021 - 12:14 Pfizer Announces Retirement of Chief Financial Officer Frank DAmelio
Wed, 11/17/2021 - 07:59 Pfizer Completes Acquisition of Trillium Therapeutics
Thu, 09/30/2021 - 13:08 Japans MHLW Approves Pfizers CIBINQO (abrocitinib) for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
Fri, 09/24/2021 - 17:18 Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency

InfoBox

Formation1900
HeadAlbert Bourla
FounderCharles Pfizer
Employees96,500
LocationUnited States
HomePagewww.pfizer.com
Facebookwww.facebook.com/Pfizer
Twittertwitter.com/pfizer_news
YouTubewww.youtube.com/user/pfizernews
LinkedInwww.linkedin.com/companies/pfizer
Wikipediaen.wikipedia.org/wiki/Pfizer